Publication|Articles|March 19, 2026
- Pharmaceutical Executive: March 2026
- Volume 46
- Issue 2
Pharmaceutical Executive: March 2026 Interactive Digital Edition
View the Pharmaceutical Executive March 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
5 months ago
Data and Trust5 months ago
Andrew Hall: The Discipline of Conviction5 months ago
Cautious Momentum: Biopharma Review and Outlook5 months ago
Orphan Product Risk ContractingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
3
Who Pays for Tariff Driven Input Cost Increases?
4
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
5
